Wilmington, Delaware, United States, Transparency Market Research Inc.: Carrier screening is a genetic test used to determine if a healthy person is a carrier of a recessive genetic disease or a gene for certain genetic disorders.
Wilmington, Delaware, United States, Transparency Market Research Inc.: Carrier screening is a genetic test used to determine if a healthy person is a carrier of a recessive genetic disease or a gene for certain genetic disorders. It provides life-lasting information about an individual's reproductive risk and the chances of having a child with a genetic disease.
Read Report Overview - https://www.transparencymarketresearch.com/carrier-screening-market.html
Key Drivers and Restraints of Global Carrier Screening Market
Globally, the average age of first time mothers has been increasing, especially in developed countries such as the U.S., England, France, Germany, Italy, and Japan. Financial stability, rise in literacy rates, and social factors are key aspects for advancing maternal age. The risk of fetal chromosomal abnormalities is directly related to the increase in maternal age. According to the American Academy of Family Physicians (AAFP), the risk of fetal chromosomal abnormalities increases gradually up to the age of 30, and rises exponentially beyond that. This growth in average maternal age is estimated to boost the incidence of chromosomal abnormalities, leading to a rise in demand for carrier screening.
Request for Report Brochure - https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=76319
People with the Down syndrome have high risk of contracting Alzheimer’s disease, heart defects, pre-leukemia, and hearing issues. Various organizations such as The American College of Obstetricians and Gynecologists (ACOG), International Society for Prenatal Diagnosis, and the U.S. National Society of Genetic Counselors (NSGC) create awareness about precautions and issues pertaining to the fetus. Various organizations are developing new technologies to ensure safety for both the mother and fetus. They are also working on increasing awareness among pregnant women. Furthermore, doctors advise different prenatal and newborn carrier screening tests for pregnant mothers during regular health checkups. This helps create awareness among them. As a result, most of the pregnant women in the U.S. undergo testing for carrier screening.
Companies operating in the global carrier screening market primarily adopt the next generation sequencing (NGS) approach to detect fetal abnormalities. Continuous efforts are being made by manufacturers to improve the existing technology and introduce a new breakthrough technology in the market. Recent advances in molecular technology have catapulted options for carrier screening from a gene-by-gene evaluation to panels spanning many disorders at one time.
Request for Custom Research - https://www.transparencymarketresearch.com/sample/sample.php?flag=CR&rep_id=76319
Chain Reaction Technology Segment to Lead Global Carrier Screening Market
In terms of revenue, the polymerase chain reaction technology segment is expected to capture nearly 50% share of the market by 2027. It is anticipated to be a highly lucrative segment of the global carrier screening market during the forecast period. Different types of polymerase chain reactions (PCR) are being used in prenatal diagnosis genetic testing such as standard PCR, real-time PCR, digital PCR, and RT-PCR. These polymerase chain reactions (PCRs) play an important role in determination of gene expression, microRNA expression, and genotyping. DNA sequencing allows rapid amplification of small fragments of DNA and RNA. The market is primarily driven by the rise in incidence of genetic diseases coupled with better precision and reliability of the technique.
The carrier screening market is significantly underpenetrated in many countries in Asia such as Japan, India, and China vis-à-vis that in North America and Europe. This can be primarily ascribed to the lack of access to genetic testing and low level of awareness in countries in Asia. The region offers offer immense opportunities for the carrier screening market, led by the presence of a large population base and continuous economic development in countries. High birth rates in India and China are projected to provide a major advantages to developers, provided the tests available are cost-effective. In such a scenario, focusing on these emerging markets is likely to enable prenatal and newborn genetic testing developers and providers to record high growth in revenue.
Make an Enquiry Before Buying - https://www.transparencymarketresearch.com/sample/sample.php?flag=EB&rep_id=76319
Key Players Operating in Global Carrier Screening Market
Manufacturers in the global carrier screening market are increasingly investing in research and development of new and innovative techniques to manufacture advanced products for screening. These players are also focusing on offering highly efficient and reliable products.
Leading companies operating in the global carrier screening market are:
- Eurofins Scientific
- Quest Diagnostics
- Sema4
- Myriad Genetics
- Illumina
- Thermo Fisher Scientific
- Invitae
- OPKO Health
- Fulgent Genetics
More Trending Reports by Transparency Market Research –
Pulmonary Arterial Hypertension Market: The global pulmonary arterial hypertension (PAH) market is expected to reach the value of US$ 13.5 Bn by the end of 2028.It is estimated to expand at a CAGR of 5.4% from 2021 to 2028
Chronic Obstructive Pulmonary Disease (COPD) Treatment Market: The value of the global chronic obstructive pulmonary disease (COPD) treatment market was clocked at US$ 19.8 Bn in 2021.
Forensic Technologies Market: The global forensic technologies market is expected to reach the value of US$ 87.4 Bn by the end of 2028.It is estimated to expand at a CAGR of 13.2% from 2021 to 2028.
Microbiology Culture Market: The U.S. microbiology culture market is expected to reach the value of US$ 5.4 Bn by the end of 2031.It is estimated to expand at a CAGR of 7.8% from 2021 to 2031.
Nanomedicine Market: The global nanomedicine market is expected to reach the value of US$ 512.5 Bn by the end of 2028.It is estimated to expand at a CAGR of 12.6% from 2021 to 2028.
Smart Medical Devices Market: The global smart medical devices market is expected to reach the value of US$ 70.1 Bn by the end of 2028. It is estimated to expand at a CAGR of 7.5% from 2021 to 2028.
Bioinformatics Market: The global bioinformatics market is expected to reach the value of US$ 44.9 Bn by the end of 2028.It is estimated to expand at a CAGR of 5.9% from 2021 to 2028.
Taurine Market: The global taurine market is expected to reach the value of US$ 0.3 Bn by the end of 2031.It is estimated to expand at a CAGR of 5.3% from 2021 to 2031.
About Us
Transparency Market Research, a global market research company registered at Wilmington, Delaware, United States, provides custom research and consulting services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insights for thousands of decision makers. Our experienced team of Analysts, Researchers, and Consultants use proprietary data sources and various tools & techniques to gather and analyze information.
Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.
For More Research Insights on Leading Industries, Visit Our YouTube Channel and hit subscribe for Future Update - https://www.youtube.com/channel/UC8e-z-g23-TdDMuODiL8BKQ
Contact
Rohit Bhisey
Transparency Market Research Inc.
CORPORATE HEADQUARTER DOWNTOWN,
1000 N. West Street,
Suite 1200, Wilmington, Delaware 19801 USA
Tel: +1-518-618-1030
USA – Canada Toll Free: 866-552-3453
Website: https://www.transparencymarketresearch.com
Blog: https://tmrblog.com
Email: sales@transparencymarketresearch.com